Biosimilar Versus Originator Pegfilgrastim for Preventing Chemotherapy-Induced Neutropenia: A Phase III Randomized, Multicenter, Evaluator-Blinded, Noninferiority Study

por Kowalyszyn, Ruben D., Fein, Luis E., Richardet, Martin E., Varela, Mirta S., Ortiz, Eduardo, Micheri, Cristian, Zarba, Juan J., Kahl, Susana, Klimovsky, Ezequiel, Federico, Andrea A., Cassini, Jorge H., Cortese, Gustavo, Lago, Nestor
Publicado 2022

Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer

por Rugo, Hope S., Umanzor, Gerardo A., Barrios, Francisco J., Vasallo, Rosa H., Chivalan, Marco A., Bejarano, Suyapa, Ramírez, Julio R., Fein, Luis, Kowalyszyn, Ruben D., Kramer, E. Douglas, Wang, Hui, Kwan, Min-Fun R., Cutler, David L.
Publicado 2023